Revisiting host preference in the Mycobacterium tuberculosis complex: Experimental infection shows M. tuberculosis H37Rv to be avirulent in cattle

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Whelan, Adam O ^a   Coad, Michael ^a   Cockle, Paul J ^a,c   Hewinson, Glyn ^a   Vordermeier, Martin ^a   Gordon, Stephen V ^a,b  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BOVINE TUBERCULOSIS; CATTLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPERIMENTAL HOST; EXPERIMENTAL INFECTION; GENE SEQUENCE; GENOTYPE; IMMUNE STATUS; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TISSUE CULTURE; TUBERCULIN TEST; ANIMAL; ANIMAL DISEASE; BACTERIAL COUNT; CATTLE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; TUBERCULOSIS; VIRULENCE;

ANIMALIA; BOS; BOVINAE; MAMMALIA; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

ANIMALS; CATTLE; CATTLE DISEASES; COLONY COUNT, MICROBIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON-GAMMA; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 77649126539     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008527     Document Type: Article

References (27)

1. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
2. Garnier T, Eiglmeier K, Camus JC, Medina N, Mansoor H, et al. (2003) The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A 100: 7877-7882.
3. Smith NH, Kremer K, Inwald JJ, Dale J, Driscoll JR, et al. (2006) Ecotypes of the Mycobacterium tuberculosis complex. J Theo Biol 239: 220-225.
4. Smith T (1896) Two varieties of the tubercle bacillus from mammals. Trans Assoc Am Physicians 11: 75-95.
5. von Behring E (1901) Serum Therapy in Therapeutics and Medical Science. Nobel Lectures, Physiology or Medicine 1901-1921: World Scientific Publishing Company.
6. Koch R (1901) An address on the fight against Tuberculosis. BMJ 2: 189-193.
7. Berg S, Firdessa R, Habtamu M, Gadisa E, Mengistu A, et al. (2009) The burden of mycobacterial disease in ethiopian cattle: implications for public health. PLoS One 4: e5068.
8. Cadmus S, Palmer S, OkkerM, Dale J, Gover K, et al. (2006) Molecular analysis of human and bovine tubercle bacilli from a local setting in Nigeria. J Clin Microbiol 44: 29-34.
9. Chen Y, Chao Y, Deng Q, Liu T, Xiang J, et al. (2009) Potential challenges to the Stop TB Plan for humans in China; cattle maintain M. bovis and M. tuberculosis. Tuberculosis (Edinb) 89: 95-100.
10. Ocepek M, Pate M, Zolnir-Dovc M, Poljak M (2005) Transmission of Mycobacterium tuberculosis from human to cattle. J Clin Microbiol 43: 3555-3557.
11. Srivastava K, Chauhan DS, Gupta P, Singh HB, Sharma VD, et al. (2008) Isolation of Mycobacterium bovis & M. tuberculosis from cattle of some farms in north India-possible relevance in human health. Indian J Med Res 128: 26-31.
12. Gallagher J, Horwill DM (1977) A selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis. J Hyg (Lond) 79: 155-160.
13. Buddle BM, Keen D, Thomson A, Jowett G, McCarthy AR, et al. (1995) Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res Vet Sci 59: 10-16.
14. Vordermeier HM, Cockle PC, Whelan A, Rhodes S, Palmer N, et al. (1999) Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle. Clin Diagn Lab Immunol 6: 675-682.
15. Vordermeier HM, Chambers MA, Cockle PJ, Whelan AO, Simmons J, et al. (2002) Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 70: 3026-3032.
16. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, et al. (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35: 907-914.
17. Cockle PJ, Gordon SV, Lalvani A, Buddle BM, Hewinson RG, et al. (2002) Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect Immun 70: 6996-7003.
18. Vordermeier HM, Whelan A, Cockle PJ, Farrant L, Palmer N, et al. (2001) Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin Diagn Lab Immunol 8: 571-578.
19. van Drunen Littel-van den H, Braun RP, Lewis PJ, Karvonen BC, Baca-Estrada ME, et al. (1998) Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J Gen Virol 79 (Pt 4): 831-839.
20. Bean AG, Roach DR, Briscoe H, France MP, Korner H, et al. (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162: 3504-3511.
21. Golby P, Hatch KA, Bacon J, Cooney R, Riley P, et al. (2007) Comparative transcriptomics reveals key gene expression differences between the human and bovine pathogens of the Mycobacterium tuberculosis complex. Microbiology 153: 3323-3336.
22. Inwald J, Jahans K, Hewinson RG, Gordon SV (2003) Inactivation of the Mycobacterium bovis homologue of the polymorphic RD1 gene Rv3879c (Mb3909c) does not affect virulence. Tuberculosis (Edinb) 83: 387-393.
23. Wiker HG, Nagai S, Hewinson RG, Russell WP, Harboe M (1996) Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv. Scand J Immunol 43: 374-380.
24. Said-Salim B, Mostowy S, Kristof AS, Behr MA (2006) Mutations in Mycobacterium tuberculosis Rv0444c, the gene encoding anti-SigK, explain high level expression of MPB70 and MPB83 in Mycobacterium bovis. Mol Microbiol 62: 1251-1263.
25. Chatterjee D, Bozic CM, Knisley C, Cho SN, Brennan PJ (1989) Phenolic glycolipids of Mycobacterium bovis: new structures and synthesis of a corresponding seroreactive neoglycoprotein. Infect Immun 57: 322-330.
26. Jarnagin JL, Brennan PJ, Harris SK (1983) Rapid identification of Mycobacterium bovis by a thin-layer chromatographic technique. Am J Vet Res 44: 1920-1922.
27. Reed MB, Domenech P, Manca C, Su H, Barczak AK, et al. (2004) A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431: 84-87.